Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series) - Image 1

£119.60

CRC Press Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

Name: Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 119.6 GBP
Availability: InStock

Public Health

This is the most expensive it has ever been. Walk away.

£120 today · previous high £120 · all-time low £88

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 625 days • 625 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 625 days • 4 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £107-113 (283 days, 45.3%)

Price range: £88 - £120

Price levels: 4 price ranges over 625 days

Description

Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field. Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions. Features Provides the first book and a single source of information on RWE in drug development Covers a broad array of topics on outcomes- and value-based RWE assessments Demonstrates proper Bayesian application and causal inference for real-world data (RWD) Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 036702621X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues > Public Health
Domain: Amazon UK
Release Date: 11 February 2021
Listed Since: 18 October 2019

Barcode

No barcode data available

CRC Press Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Springer - Real-World Evidence in Medical Product Development

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Statistical Issues in Drug Development (Statistics in Practice)

Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Biomarker and Early Clinical Development

Statistical Methods in Biomarker and Early Clinical Development

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Multiple Testing Problems in Pharmaceutical Statistics: 33 (Chapman & Hall/CRC Biostatistics Series)

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

Statistical Thinking for Non-Statisticians in Drug Regulation

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

New Drug Development: An Introduction to Clinical Trials: Second Edition

Cross-over Trials in Clinical Research: 5 (Statistics in Practice)